EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Prognostic Value of Frailty in Patients With Takotsubo Cardiomyopathy

Carlos Diaz-Arocutipa, Adrian V Hernandez

Clinical Cardiology · 2025

DOI: 10.1002/clc.70054 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Cardiology, 2025. Verfasst von Carlos Diaz-Arocutipa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Revisiones Sistemáticas y Meta-análisis (URSIGET), Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru. Hauptthemen laut MEDLINE: Frailty, Takotsubo Cardiomyopathy. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is scarce data on the prognostic value of frailty in patients with Takotsubo cardiomyopathy (TCM). This study aimed to assess the association between frailty and in‐hospital outcomes in patients with TCM.

Methods

Adult admissions with TCM were included using the 2016−2019 National Inpatient Sample database. The primary outcome was in‐hospital mortality and secondary outcomes included cardiogenic shock, in‐hospital cardiac arrest, stroke/transient ischemic attack (TIA), length of hospital stay, and total charges. Frailty was assessed using the hospital frailty risk score (HFRS), and admissions were divided into two groups: low risk and intermediate/high risk of frailty. Logistic regression was used to estimate odds ratios (OR) with their 95% confidence intervals (CI).

Results

A total of 32 360 patients were included; the median age was 67 (58−76) years and 90% were female. The median HFRS was 2.6 (1.1−5.3). In the adjusted models, in‐hospital mortality was significantly higher in the intermediate/high risk of frailty group (OR 3.60, 95% CI 2.16−6.02) compared to the low‐risk group. Similarly, admissions with intermediate/high risk of frailty had a significantly higher risk of cardiogenic shock (OR 3.66, 95% CI 2.77−4.80), in‐hospital cardiac arrest (OR 2.57, 95% CI 1.55−4.24), and stroke/TIA (OR 5.68, 95% CI 3.51−9.20). There was a significantly higher hospital charges and length of hospital stay in the intermediate/high‐risk group. In the restricted cubic spline regression models, the frailty score was nonlinearly associated with all outcomes.

Conclusions

Our results suggest that frailty is useful as a prognostic factor for in‐hospital events in patients with TCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FrailtyTakotsubo CardiomyopathyAgedFemaleHumansMaleMiddle AgedHospital MortalityLength of StayPrognosisRetrospective StudiesRisk AssessmentRisk FactorsShock, Cardiogenic

Stichwörter der Autor:innen

NISTakotsubo cardiomyopathyfrailtymortalityprognosis

Autor:innen und Institutionen

  • Unidad de Revisiones Sistemáticas y Meta-análisis (URSIGET), Vicerrectorado de Investigación, Universidad San Ignacio de Loyola, Lima, Peru.
  • Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA.

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Diaz-Arocutipa, C., & Hernandez, A. V. (2025). Prognostic Value of Frailty in Patients With Takotsubo Cardiomyopathy. Clinical Cardiology. https://doi.org/10.1002/clc.70054

Vancouver

Diaz-Arocutipa C, Hernandez AV. Prognostic Value of Frailty in Patients With Takotsubo Cardiomyopathy. Clinical Cardiology. 2025. doi:10.1002/clc.70054

BibTeX
@article{DiazArocutipa2025,
  author = {Diaz-Arocutipa, Carlos and Hernandez, Adrian V},
  title = {Prognostic Value of Frailty in Patients With Takotsubo Cardiomyopathy},
  journal = {Clinical Cardiology},
  year = {2025},
  doi = {10.1002/clc.70054}
}
Kostenlos starten →